Urinary crosslinked N-telopeptide of type I collagen and crosslaps as markers of bone resorption in patients with Paget's disease of bone

被引：0
|
作者：
Iqbal, SJ [1 ]
Whittaker, P [1 ]
Davies, T [1 ]
机构：
[1] Leicester Royal Infirm, Dept Chem Pathol, Leicester LE1 5WW, Leics, England
来源：
BONE | 1999年 / 24卷 / 05期
关键词：
D O I：
10.1016/S8756-3282(99)00055-1
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：52S / 52S
页数：1
相关论文
共 50 条
  • [1] The use of urinary N-telopeptide of type I collagen (NTx) to monitor response to treatment of Paget's disease of bone.
    Bone, H
    Lyles, K
    Tucci, J
    Lombardi, A
    Barrett, J
    Flessland, K
    Mallinak, N
    Cain, D
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 1996, 11 : M757 - M757
  • [2] The effect of hormone replacement therapy in postmenopausal women on urinary C-telopeptide and N-telopeptide of Type I collagen, new markers of bone resorption
    Taga, M
    Uemura, T
    Minaguchi, H
    [J]. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1998, 21 (03) : 154 - 159
  • [3] The effect of hormone replacement therapy in postmenopausal women on urinary C-telopeptide and N-telopeptide of Type I collagen, new markers of bone resorption
    Michiyoshi Taga
    T. Uemura
    H. Minaguchi
    [J]. Journal of Endocrinological Investigation, 1998, 21 : 154 - 159
  • [4] CHANGES OF N-TELOPEPTIDE CROSSLINKED TYPE 1 COLLAGEN IN BREAST CANCER PATIENTS WITH BONE METASTASIS RECEIVING DENOSUMAB
    Mizuno, Yutaka
    Kurata, Nobuhiko
    Mori, Toshihiro
    Miyauchi, Masayuki
    [J]. ANNALS OF ONCOLOGY, 2014, 25
  • [5] Diagnostic value of urinary N-telopeptide of type I collagen in prostate cancer: Comparison with bone scintigraphy.
    Fukumitsu, N
    Uchiyama, M
    Mori, Y
    Harada, J
    Yanada, S
    Hatano, T
    Igarashi, H
    Nakata, J
    Gotou, E
    [J]. JOURNAL OF NUCLEAR MEDICINE, 1999, 40 (05): : 195P - 195P
  • [6] Type I collagen C-telopeptide degradation products as bone resorption markers
    Pedersen, BJ
    Ravn, P
    Bonde, M
    [J]. JOURNAL OF CLINICAL LIGAND ASSAY, 1998, 21 (02): : 118 - 127
  • [7] The use of a point of care device for monitoring the bone resorption biomarker urinary N-telopeptide in cancer patients with bone metastases
    Lester, Jim E.
    Brown, Janet E.
    Hannon, Rosemary A.
    Ellis, Sue P.
    Horsman, Janet M.
    Purohit, Omprakash P.
    Coleman, Robert E.
    [J]. BONE, 2010, 46 (03) : 801 - 805
  • [8] Utility of urinary type I collagen cross-linked N-telopeptide as a prognostic indicator in breast cancer patients with bone metastases
    Masato Shizuku
    Masahiro Shibata
    Mai Okumura
    Dai Takeuchi
    Toyone Kikumori
    Yutaka Mizuno
    [J]. Breast Cancer, 2020, 27 : 1065 - 1071
  • [9] Utility of urinary type I collagen cross-linked N-telopeptide as a prognostic indicator in breast cancer patients with bone metastases
    Shizuku, Masato
    Shibata, Masahiro
    Okumura, Mai
    Takeuchi, Dai
    Kikumori, Toyone
    Mizuno, Yutaka
    [J]. BREAST CANCER, 2020, 27 (06) : 1065 - 1071
  • [10] Increased urinary N-telopeptide cross-linked type 1 collagen predicts bone loss in patients with inflammatory bowel disease
    Dresner-Pollak, R
    Karmeli, F
    Eliakim, R
    Ackerman, Z
    Rachmilewitz, D
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2000, 95 (03): : 699 - 704
12345